首页> 外文期刊>Alternatives to laboratory animals: ATLA >Where does iPS Cell Technology Leave the Promoters of the Creation and Use of Admixed Animal-human Embryos?
【24h】

Where does iPS Cell Technology Leave the Promoters of the Creation and Use of Admixed Animal-human Embryos?

机译:iPS细胞技术在哪里离开了动物和人类混合胚胎创造和使用的促进者?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The aim of the Human Fertilisation and Embryology Act 2008 is to provide "revised and updated legislation for assisted reproduction and changes to the regulation and licensing of the use of embryos in research and therapy". However, its "provision for research on different types of embryos" raises a number of serious scientific questions and ethical dilemmas, principally because it permits the controlled creation and use of admixed animal-human embryos, by replacing the nuclei of animal eggs with human nuclei or cells, in order to increase the availability of human embryonic stem cells for research on a wide range of serious diseases.
机译:2008年《人类受精和胚胎学法》的目的是提供“修订和更新的法律,以协助生殖以及研究和治疗中使用胚胎的法规和许可的变更”。但是,其“研究不同类型胚胎的规定”引起了一系列严重的科学问题和伦理困境,这主要是因为它允许通过用人类核替代动物卵核来控制地创造和使用混合的动物-人类胚胎。或细胞,以增加人类胚胎干细胞用于研究各种严重疾病的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号